BSECompany Update4d ago · 8 Aug 2026, 04:06 pm
As enclosed
Medi Assist Healthcare Services Ltd · 544088
✦ AI SummaryFundraise
Medi Assist Healthcare Services Ltd has filed a statement of deviation or variation in the utilization of funds raised through a preferential issue for the quarter ended June 30, 2026, stating that there has been no deviation or variation in the use of funds raised. The company has also enclosed a monitoring agency report issued by CARE Ratings Limited.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Medi Assist Healthcare Services Ltd - 544088 - Regulation 32- Statement Of Deviation & Variation For The Quarter Ended June 30, 2026
Attachments (1)
📄pdf
Download →
533cc32c-ae01-4e9e-be1a-ae897c7c38a6.pdf
View document text
August 08, 2026
To, To,
Listing Department Department of Corporate Services
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers, Dalal Street,
Bandra (East), Mumbai – 400 051 Mumbai – 400 001
Symbol: MEDIASSIST Scrip Code: 544088
Dear Sir/ Madam,
Sub: Statement of deviation or variation in utilisation of funds raised through Preferential Issue
for the quarter ended June 30, 2026 and Monitoring Agency Report issued by CARE Ratings
Limited
Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
we are enclosing the statement of deviation or variation regarding the utilization of funds raised
through Preferential Issue for the quarter ended June 30, 2026. The said statement has been reviewed
by the Audit Committee and Board at their meeting held on August 08, 2026.
We are also enclosing the Monitoring Agency Report issued by CARE Ratings Limited, appointed to
monitor the utilization of the proceeds.
Furthermore, we confirm that there has been no deviation or variation in the utilization of funds from
the objects stated in the explanatory statement to the notice for the Preferential Issue.
Brief details of the Statement is enclosed as Annexure A.
We request you to take the above information on record.
For Medi Assist Healthcare Services Limited
Rashmi B V
Company Secretary & Compliance Officer
Membership No: A38729
Encl.: As above
Annexure A
Statement on deviation / variation in utilisation of funds raised
Name of the listed entity Medi Assist Healthcare Services Limited
Mode of Fund Raising Preferential Issue
Date of Raising Funds October 10, 2025
Amount Raised INR 1,98,00,35,000/-
Report filed for Quarter ended June 30, 2026
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CARE Ratings Limited
Is there a Deviation / Variation in use of funds There is no deviation/variation in use of funds raised
raised
yes, whether the same is pursuant to change in Not applicable
terms of a contract or objects, which was approved
by the shareholders
If Yes, Date of shareholder Approval Not applicable
Explanation for the Deviation / Variation Not applicable
Comments of the Audit Committee/Board after There is no deviation/variation in use of funds raised.
review Proceeds from Investment in Mutual Funds of Rs.7.50
crore were credited to the monitoring account on 29-
06-2026. This redemption was made for the purpose
approved by the Board. This Rs.7.5 crore was
transferred to the current account of the company for
the purpose approved by the board. Documents were
submitted to Bank for payment on 29-06-2026. Since
this transaction involves forex payments, debit from
our account took 2~3 days once the money got
credited to our account. Out of Rs.7.5 crore, Rs.4.72
crore got debited on 30-06-2026 and balance Rs.2.78
crore got debited on 01-07-2026 morning. Funds lying
in current account were used for approved purpose
only.
Comments of the auditors, if any No comments
Objects for which funds have been raised and where there has been a deviation, in the following table
Original Modified Original Modified Funds Amount Remarks,
Objects Object, if any Allocation allocation, Utilised of if any
(Rs. In Crores) if any (Rs. In Deviation/
Crores) Variation
for the
quarter
according
applicable
object
For Not Applicable 150.00 None 148.40 None Not
undertaking Applicable
investment in
Medi Assist
Insurance TPA
Pvt. Limited, a
wholly-owned
material
subsidiary of
the Company
(“Subsidiary”),
in the form of
equity/ quasi
equity, debt/
loan
instruments,
which will be
utilized by the
Subsidiary to
prepay/repay,
in full or part,
all or a
portion of
certain
outstanding
borrowings
availed by the
Subsidiary
from banks,
nonbanking
finance
companies
and other
lenders, if
any.
(Investment
in Subsidiary
for Debt
Prepayment/
Repayment)
Up to 25% Not Applicable 48.0035 None 4.72 None The
(twenty-five company
percent) of utilized
the Issue Rs.4.72
Proceeds will Crore
be utilised for towards
general acquisition
corporate of additional
purposes, stake in its
which subsidiary,
includes, inter Mayfair We
alia, meeting Care
ongoing Limited, UK
general as approved
corporate by the Board
exigencies at its
and meeting
contingencies, held on June
expenses and 24, 2026
investments
of the
Company as
applicable in
such a
manner and
proportion as
may be
decided by
the Board
from time to
time, and/or
any other
general
purposes as
may be
permissible
under
applicable
laws (General
Corporate
Purposes)
TOTAL - 198.0035 - 153.12 - -
Devia(cid:415)on or varia(cid:415)on could mean:
a) Devia(cid:415)on in the objects or purposes for which the funds have been raised or
b) Devia(cid:415)on in the amount of funds actually u(cid:415)lized as against what was originally disclosed or
c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, le(cid:425)er of
o(cid:299)er, etc.
The funds raised were transferred from the escrow account to the bank account of the Company in
two tranches on December 30, 2025 and December 31, 2025.
For Medi Assist Healthcare Services Limited
Rashmi B V
Company Secretary & Compliance Officer
Membership No: A38729
No. CARE/ARO/GEN/2026-27/1129
The Board of Directors
Medi Assist Healthcare Services Limited
AARPEE Chambers, SSRP Building,
7th Floor, Andheri Kurla Road,
Marol Co-operative Industrial Estate Road, Gamdevi, Marol Bazar,
Andheri East, Mumbai, Maharashtra 400059
August 08, 2026
Dear Sir/Ma’am,
Monitoring Agency Report for the quarter ended June 30, 2026 in relation to the preferential issue of
Medi Assist Healthcare Services Limited (“the Company”)
We write in our capacity of Monitoring Agency for the preferential issue for the amount aggregating to Rs. 198.00 crore of
the Company and refer to our duties cast under 162A of the Securities & Exchange Board of India (Issue of Capital &
Disclosure Requirements) Regulations.
In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026 as per aforesaid
SEBI Regulations and Monitoring Agency Agreement dated September 15, 2025 and January 09, 2026.
Request you to kindly take the same on records.
Thanking you,
Yours faithfully,
Komal Israni
Assistant director
Komal.israni@careedge.in
Report of the Monitoring Agency
Name of the issuer: Medi Assist Healthcare Services Limited
For quarter ended: June 30, 2026
Name of the Monitoring Agency: CARE Ratings Limited
(a) Deviation from the objects: Nil
(b) Range of Deviation: Not applicable
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of
the issue based on the information provided by the Issuer and information obtained from sources believed by it to be
accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/
certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA
which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and
opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner
whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship
between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not
act as an expert as defined under Section 2(38) of the Companies Act, 2013.
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report
pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there
is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds
by the issuer, or while undertaking credi
[Showing first 8,000 characters — download PDF for full document]